NFKBIA and glioblastoma: We previously found that monoallelic deletion of NFKBIA occurs in about 25% of glioblastomas and convey a dismal clinical prognosis.8 However, aberrant constitutive activation of NF-κB occurs in most glioblastomas,10 suggesting additional mechanisms of NF-κB activation.